Immunological Intervention Triggered by Decreasing CD34 (+) Lineage-Specific Donor Cell Chimerism to Prevent Relapse of Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

Rosenow F, Silling G, Almut B, Mueller-Tidow C, Koschmieder S, Bisping G, Krug U, Buechner T, Berdel WE, Kienast J, Stelljes M